🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The COVID-19 pandemic continues to rage and most of the world is facing a s...
Status
Completed
Location
CHU Brugmann
Start Date
2021-01-15
Trial ID
NCT04799652
Treatments Being Tested
The purpose of this study is to evaluate the safety and efficacy of IFN-α c...
Status
Unknown
Location
The First Affiliated Hospital of Soochow University
Start Date
2019-04-01
Trial ID
NCT04534634
Treatments Being Tested
The purpose of this study is to assess the safety, tolerability and immunog...
Status
Completed
Location
Multiple Locations
Start Date
2006-10
Trial ID
NCT00366899
Treatments Being Tested
This is a phase I clinical study to evaluate the safety and efficacy of CAR...
Status
Unknown
Location
Shandong Second Provincial General Hospital
Start Date
2021-09-06
Trial ID
NCT05420493
Treatments Being Tested
The purpose of this study is to generate safety, reactogenicity (assessment...
Status
Completed
Location
GSK Investigational Site
Start Date
2019-08-05
Trial ID
NCT04026009
Vaccines are one of our most effective public health tools but many who nee...
Status
Completed
Location
Massachusetts General Hospital
Start Date
2014-04
Trial ID
NCT02057263
Treatments Being Tested
RATIONALE: Vaccines made from white blood cells treated with antigens may m...
Status
Completed
Location
Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support
Start Date
1997-04
Trial ID
NCT00019214
Treatments Being Tested
This project plans to learn more about whether sending text messages to par...
Status
Completed
Location
Fundacion para la Salud Integral de los Guatemaltecos CU
Start Date
2016-03-01
Trial ID
NCT02567006
Treatments Being Tested
The purpose of this study is to complete the total safety database size for...
Status
Completed
Location
GSK Investigational Site
Start Date
2019-07-19
Trial ID
NCT03954743
Randomized, observer-blinded, multicenter, dose-escalation Phase 1 clinical...
Status
Completed
Location
Optimal Research, LLC
Start Date
2018-03-05
Trial ID
NCT03382964
Treatments Being Tested